Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
World-first Approval For Multiple Myeloma Drug APLIDIN(R)
2018-12-11 15:10
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million
2018-12-11 09:47
CStone Pharmaceuticals Appoints Former MSD Global Oncology Early Development Executive Director Archie Tse, M.D., Ph.D., as the newly established SVP, Chief Translation Medicine Officer
2018-12-10 15:38
WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market"
2018-12-06 18:12
CARsgen Presents Preliminary Results of CAR-BCMA T Cell Therapy at ASH 2018
2018-12-04 20:00
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs
2018-11-29 15:40
Spring Pharmaceutical Group Inc. Starts Harvesting Seed Pods from Its Acer Truncatum Bunge Planting Bases
2018-11-27 20:00
Foresee Pharmaceuticals Announces Completion of Last Patient Visit in Registration Phase 3 Study of LMIS 25 mg (fp-001) for the Treatment of Advanced Prostate Cancer
2018-11-26 21:30
Seegene launches a new anti-microbial drug resistance test kit, replacing the conventional culture method
2018-11-26 21:00
CStone initiates a bridging Phase I clinical trial for PD-1 antibody CS1003 with first patient dosed in China
2018-11-19 12:54
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-877, an Autotaxin Inhibitor for Idiopathic Pulmonary Fibrosis
2018-11-19 07:00
MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210
2018-11-16 05:01
Foresee Pharmaceuticals Announces Sr. VP of Pharmaceutics and Manufacturing Appointment
2018-11-15 20:33
TWi Biotechnology, Inc. Announces Last Patient Enrolled in Phase 2 Study of AC-201CR for Treatment of Hemophilic Arthropathy
2018-11-15 17:16
China Jo-Jo Drugstores Reports Second Quarter 2019 Financial Results
2018-11-14 21:30
Sanofi holds China Health Road Symposium at CIIE
2018-11-14 11:20
Spring Pharmaceutical Group Inc. Reports Financial Results for the Three and Six Months Ended September 30, 2018
2018-11-13 20:00
Metrics Contract Services Announces Serialization Capabilities at Greenville Site
2018-11-13 04:29
The First Pellino-1 Inhibitor BBT-401 Confirms Its Safety and Tolerability from the Phase I Study
2018-11-12 16:00
GCAM Adds New Plasma Collection Centers
2018-11-09 16:16
1
128
129
130
131
132
158